320 related articles for article (PubMed ID: 16835284)
1. Acromegaly and coronary disease: an integrated evaluation of conventional coronary risk factors and coronary calcifications detected by computed tomography.
Cannavo S; Almoto B; Cavalli G; Squadrito S; Romanello G; Vigo MT; Fiumara F; Benvenga S; Trimarchi F
J Clin Endocrinol Metab; 2006 Oct; 91(10):3766-72. PubMed ID: 16835284
[TBL] [Abstract][Full Text] [Related]
2. Impact of disease duration on coronary calcification in patients with acromegaly.
Herrmann BL; Severing M; Schmermund A; Berg C; Budde T; Erbel R; Mann K
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):417-22. PubMed ID: 19373755
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for development of coronary heart disease in patients with acromegaly: a five-year prospective study.
Bogazzi F; Battolla L; Spinelli C; Rossi G; Gavioli S; Di Bello V; Cosci C; Sardella C; Volterrani D; Talini E; Pepe P; Falaschi F; Mariani G; Martino E
J Clin Endocrinol Metab; 2007 Nov; 92(11):4271-7. PubMed ID: 17785352
[TBL] [Abstract][Full Text] [Related]
4. Prostatic hyperplasia: an unknown feature of acromegaly.
Colao A; Marzullo P; Ferone D; Spiezia S; Cerbone G; Marinò V; Di Sarno A; Merola B; Lombardi G
J Clin Endocrinol Metab; 1998 Mar; 83(3):775-9. PubMed ID: 9506725
[TBL] [Abstract][Full Text] [Related]
5. Ghrelin test for the assessment of GH status in successfully treated patients with acromegaly.
Pekic S; Doknic M; Miljic D; Joksimovic M; Glodic J; Djurovic M; Dieguez C; Casanueva F; Popovic V
Eur J Endocrinol; 2006 May; 154(5):659-66. PubMed ID: 16645012
[TBL] [Abstract][Full Text] [Related]
6. Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance.
Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Della Morte AM; Pivonello R; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2001 Apr; 86(4):1551-7. PubMed ID: 11297582
[TBL] [Abstract][Full Text] [Related]
7. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.
Jallad RS; Musolino NR; Salgado LR; Bronstein MD
Clin Endocrinol (Oxf); 2005 Aug; 63(2):168-75. PubMed ID: 16060910
[TBL] [Abstract][Full Text] [Related]
8. Cardiac effect of thyrotoxicosis in acromegaly.
Marzullo P; Cuocolo A; Ferone D; Pivonello R; Salvatore M; Lombardi G; Colao A
J Clin Endocrinol Metab; 2000 Apr; 85(4):1426-32. PubMed ID: 10770177
[TBL] [Abstract][Full Text] [Related]
9. Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.
Serri O; Beauregard C; Hardy J
J Clin Endocrinol Metab; 2004 Feb; 89(2):658-61. PubMed ID: 14764777
[TBL] [Abstract][Full Text] [Related]
10. Low risk of coronary artery disease in patients with acromegaly.
Dos Santos Silva CM; Lima GA; Volschan IC; Gottlieb I; Kasuki L; Neto LV; Gadelha MR
Endocrine; 2015 Dec; 50(3):749-55. PubMed ID: 25982151
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant.
Sesmilo G; Fairfield WP; Katznelson L; Pulaski K; Freda PU; Bonert V; Dimaraki E; Stavrou S; Vance ML; Hayden D; Klibanski A
J Clin Endocrinol Metab; 2002 Apr; 87(4):1692-9. PubMed ID: 11932303
[TBL] [Abstract][Full Text] [Related]
12. Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects.
Colao A; Marzullo P; Spiezia S; Ferone D; Giaccio A; Cerbone G; Pivonello R; Di Somma C; Lombardi G
J Clin Endocrinol Metab; 1999 Jun; 84(6):1986-91. PubMed ID: 10372698
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular consequences of early-onset growth hormone excess.
Colao A; Spinelli L; Cuocolo A; Spiezia S; Pivonello R; di Somma C; Bonaduce D; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2002 Jul; 87(7):3097-104. PubMed ID: 12107207
[TBL] [Abstract][Full Text] [Related]
14. Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly.
Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Florimonte L; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 1999 Jan; 84(1):17-23. PubMed ID: 9920056
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk factors in patients with uncontrolled and long-term acromegaly: comparison with matched data from the general population and the effect of disease control.
Berg C; Petersenn S; Lahner H; Herrmann BL; Buchfelder M; Droste M; Stalla GK; Strasburger CJ; Roggenbuck U; Lehmann N; Moebus S; Jöckel KH; Möhlenkamp S; Erbel R; Saller B; Mann K;
J Clin Endocrinol Metab; 2010 Aug; 95(8):3648-56. PubMed ID: 20463098
[TBL] [Abstract][Full Text] [Related]
16. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
Costa AC; Rossi A; Martinelli CE; Machado HR; Moreira AC
J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
[TBL] [Abstract][Full Text] [Related]
17. GH and IGF-I excess control contributes to blood pressure control: results of an observational, retrospective, multicentre study in 105 hypertensive acromegalic patients on hypertensive treatment.
Colao A; Terzolo M; Bondanelli M; Galderisi M; Vitale G; Reimondo G; Ambrosio MR; Pivonello R; Lombardi G; Angeli A; degli Uberti EC
Clin Endocrinol (Oxf); 2008 Oct; 69(4):613-20. PubMed ID: 18410555
[TBL] [Abstract][Full Text] [Related]
18. Coronary microvascular dysfunction may be related to IGF-1 in acromegalic patients and can be restored by therapy.
Tellatin S; Maffei P; Osto E; Dassie F; Famoso G; Montisci R; Martini C; Fallo F; Marra MP; Mioni R; Iliceto S; Vettor R; Tona F
Atherosclerosis; 2018 Feb; 269():100-105. PubMed ID: 29353224
[TBL] [Abstract][Full Text] [Related]
19. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
Freda PU; Post KD; Powell JS; Wardlaw SL
J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
